1063.3000 -2.90 (-0.27%)
NSE Jul 17, 2025 10:52 AM
Volume: 94,057
 

1063.30
-0.27%
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
Alivus Life Sciences.. has an average target of 1152.00 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended